Literature DB >> 23063907

Corticotropin-releasing factor in the mouse central nucleus of the amygdala: ultrastructural distribution in NMDA-NR1 receptor subunit expressing neurons as well as projection neurons to the bed nucleus of the stria terminalis.

Marc A Beckerman1, Tracey A Van Kempen, Nicholas J Justice, Teresa A Milner, Michael J Glass.   

Abstract

Corticotropin-releasing factor (CRF) and glutamate are critical signaling molecules in the central nucleus of the amygdala (CeA). Central amygdala CRF, acting via the CRF type 1 receptor (CRF-R1), plays an integral role in stress responses and emotional learning, processes that are generally known to involve functional NMDA-type glutamate receptors. There is also evidence that CRF expressing CeA projection neurons to the bed nucleus of the stria terminalis (BNST) play an important role in stress related behaviors. Despite the potentially significant interactions between CRF and NMDA receptors in the CeA, the synaptic organization of these systems is largely unknown. Using dual labeling high resolution immunocytochemical electron microscopy, it was found that individual somata and dendrites displayed immunoreactivity for CRF and the NMDA-NR1 (NR1) subunit in the mouse CeA. In addition, CRF-containing axon terminals contacted postsynaptic targets in the CeA, some of which also expressed NR1. Neuronal profiles expressing the CRF type 1 receptor (CRF-R1), identified by the expression of green fluorescent protein (GFP) in bacterial artificial chromosome (BAC) transgenic mice, also contained NR1, and GFP immunoreactive terminals formed synapses with NR1 containing dendrites. Although CRF and GFP were only occasionally co-expressed in individual somata and dendritic profiles, contacts between labeled axon terminals and dendrites were frequently observed. A combination of tract tracing and immunocytochemistry revealed that a population of CeA CRF neurons projected to the BNST. It was also found that CRF, or GFP expressing terminals directly contacted CeA-BNST projection neurons. These results indicate that the NMDA receptor is positioned for the postsynaptic regulation of CRF expressing CeA neurons and the modulation of signals conveyed by CRF inputs. Interactions between CRF and NMDA receptor mediated signaling in CeA neurons, including those projecting to the BNST, may provide the synaptic basis for integrating the experience of stress and relevant environmental stimuli with behaviors that may be of particular relevance to stress-related learning and the emergence of psychiatric disorders, including drug addiction.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23063907      PMCID: PMC3939808          DOI: 10.1016/j.expneurol.2012.10.009

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  76 in total

1.  Rat central amygdaloid nucleus projections to the bed nucleus of the stria terminalis.

Authors:  N Sun; L Roberts; M D Cassell
Journal:  Brain Res Bull       Date:  1991-11       Impact factor: 4.077

2.  Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex.

Authors:  M Sakanaka; T Shibasaki; K Lederis
Journal:  Brain Res       Date:  1986-09-24       Impact factor: 3.252

3.  Morphology of peptide-immunoreactive neurons in the rat central nucleus of the amygdala.

Authors:  M D Cassell; T S Gray
Journal:  J Comp Neurol       Date:  1989-03-08       Impact factor: 3.215

4.  Co-localization of CRF-ir perikarya and ACTH-ir fibers in rat brain.

Authors:  W H Pilcher; S A Joseph
Journal:  Brain Res       Date:  1984-05-07       Impact factor: 3.252

5.  Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain.

Authors:  D T Monaghan; C W Cotman
Journal:  J Neurosci       Date:  1985-11       Impact factor: 6.167

6.  Distribution of pro-opiomelanocortin-derived peptides and enkephalins in the rat central nucleus of the amygdala.

Authors:  T S Gray; M D Cassell; J Z Kiss
Journal:  Brain Res       Date:  1984-07-23       Impact factor: 3.252

7.  Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study.

Authors:  L W Swanson; P E Sawchenko; J Rivier; W W Vale
Journal:  Neuroendocrinology       Date:  1983       Impact factor: 4.914

8.  Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study.

Authors:  S Cummings; R Elde; J Ells; A Lindall
Journal:  J Neurosci       Date:  1983-07       Impact factor: 6.167

Review 9.  Brain stress systems in the amygdala and addiction.

Authors:  George F Koob
Journal:  Brain Res       Date:  2009-03-28       Impact factor: 3.252

10.  Peptide injections into the amygdala of conscious rats: effects on blood pressure, heart rate and plasma catecholamines.

Authors:  M R Brown; T S Gray
Journal:  Regul Pept       Date:  1988-05
View more
  22 in total

1.  Targeted overexpression of CRH receptor subtype 1 in central amygdala neurons: effect on alcohol-seeking behavior.

Authors:  L Broccoli; S Uhrig; G von Jonquieres; K Schönig; D Bartsch; N J Justice; R Spanagel; W H Sommer; M Klugmann; A C Hansson
Journal:  Psychopharmacology (Berl)       Date:  2018-04-26       Impact factor: 4.530

2.  Repeated norepinephrine receptor stimulation in the BNST induces sensorimotor gating deficits via corticotropin releasing factor.

Authors:  Abha Karki Rajbhandari; Vaishali P Bakshi
Journal:  Neuropharmacology       Date:  2020-04-29       Impact factor: 5.250

3.  Stress increases GABAergic neurotransmission in CRF neurons of the central amygdala and bed nucleus stria terminalis.

Authors:  John G Partridge; Patrick A Forcelli; Ruixi Luo; Jonah M Cashdan; Jay Schulkin; Rita J Valentino; Stefano Vicini
Journal:  Neuropharmacology       Date:  2016-03-22       Impact factor: 5.250

4.  5-HT2C Receptor Knockdown in the Amygdala Inhibits Neuropathic-Pain-Related Plasticity and Behaviors.

Authors:  Guangchen Ji; Wei Zhang; Lenin Mahimainathan; Madhusudhanan Narasimhan; Takaki Kiritoshi; Xiuzhen Fan; Jigong Wang; Thomas A Green; Volker Neugebauer
Journal:  J Neurosci       Date:  2016-12-23       Impact factor: 6.167

5.  Role of κ-Opioid Receptors in the Bed Nucleus of Stria Terminalis in Reinstatement of Alcohol Seeking.

Authors:  A D Lê; Douglas Funk; Kathleen Coen; Sahar Tamadon; Yavin Shaham
Journal:  Neuropsychopharmacology       Date:  2017-06-07       Impact factor: 7.853

6.  Tumor Necrosis Factor α Receptor Type 1 Activation in the Hypothalamic Paraventricular Nucleus Contributes to Glutamate Signaling and Angiotensin II-Dependent Hypertension.

Authors:  Clara Woods; Jose Marques-Lopes; Natalina H Contoreggi; Teresa A Milner; Virginia M Pickel; Gang Wang; Michael J Glass
Journal:  J Neurosci       Date:  2020-12-10       Impact factor: 6.167

7.  Angiotensin type 1a receptors on corticotropin-releasing factor neurons contribute to the expression of conditioned fear.

Authors:  R C Hurt; J C Garrett; O P Keifer; A Linares; L Couling; R C Speth; K J Ressler; P J Marvar
Journal:  Genes Brain Behav       Date:  2015-08-25       Impact factor: 3.449

8.  Diversity of Reporter Expression Patterns in Transgenic Mouse Lines Targeting Corticotropin-Releasing Hormone-Expressing Neurons.

Authors:  Yuncai Chen; Jenny Molet; Benjamin G Gunn; Kerry Ressler; Tallie Z Baram
Journal:  Endocrinology       Date:  2015-09-24       Impact factor: 4.736

9.  Sex differences in NMDA GluN1 plasticity in rostral ventrolateral medulla neurons containing corticotropin-releasing factor type 1 receptor following slow-pressor angiotensin II hypertension.

Authors:  T A Van Kempen; M Dodos; C Woods; J Marques-Lopes; N J Justice; C Iadecola; V M Pickel; M J Glass; T A Milner
Journal:  Neuroscience       Date:  2015-08-22       Impact factor: 3.590

Review 10.  Neurobiological mechanisms that contribute to stress-related cocaine use.

Authors:  John R Mantsch; Oliver Vranjkovic; Robert C Twining; Paul J Gasser; Jayme R McReynolds; Jordan M Blacktop
Journal:  Neuropharmacology       Date:  2013-08-02       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.